表紙
市場調査レポート

心調律管理の米国市場

U.S. Markets for Cardiac Rhythm Management

発行 Medtech Insight 商品コード 324808
出版日 ページ情報 英文 118 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
心調律管理の米国市場 U.S. Markets for Cardiac Rhythm Management
出版日: 2015年02月24日 ページ情報: 英文 118 Pages
概要

米国の心調律管理装置 (CRM装置) は今後2.9%のCAGRで拡大し、約11億米ドルに成長すると予測されています。診断用CRM製品は4.8%、治療用CRM製品は2.7%のCAGRで成長すると予測されています。

当レポートは、米国の心調律管理装置 市場について調査し、処置数・市場の予測、各製品市場の主な成長影響因子、米国の主要サプライヤーの市場シェア・売上予測、各製品市場の主要サプライヤーの製品ポートフォリオ分析、および製品市場の発展を変化し得る革新的な技術などをまとめ、お届け致します。

エグゼクティブサマリー

第1章 心調律疾患の概要

  • 心臓・循環系
  • 心臓伝導系
  • 主な心調律疾患
    • 徐脈
    • 洞不全症候群
    • 心臓ブロック
    • 頻拍
    • 心房細動
    • 心室細動

第2章 米国の心調律管理装置市場

  • 診断用心調律管理装置:市場分析
    • 心電図記録製品:市場分析
      • 製品の数
      • 製品
      • 市場予測
      • 競合分析
    • 電気生理学製品:市場分析
  • 治療用心調律管理装置:市場分析
    • 心臓再同期療法製品:市場分析
      • 植え込み型心臓ペーシングシステム
      • 一時的ペーシングシステム
      • 処置数
      • 製品
      • 市場予測
      • 競合分析
    • 体外除細動器:市場分析
    • 植え込み型除細動器:市場分析
    • 心臓再同期療法:市場分析
    • 不整脈アブレーション

付録:企業リスト

目次
Product Code: A233

Cardiac rhythm management (CRM) devices, which encompasses diagnostic and therapeutic systems, represents a well-established market that is still seeing innovation in some of the segments that compose it. Over the forecast period covered in this report, the estimated value of the U.S. market for CRM devices is expected to grow by approximately $1.1 billion at compound annual growth rate (CAGR) of 2.9%; of this holistic market, diagnostic CRM products are forecasted to grow at a CAGR of 4.8%, while therapeutic CRM products will grow at a CAGR of 2.7%.

Contents of this report include:

  • procedure and market forecasts for the years 2014 to 2019;
  • key factors influencing the growth of individual product markets;
  • estimated market shares and sales among major U.S. suppliers;
  • major supplier product portfolio analysis in individual product markets; and,
  • innovative technology that could potentially change the way product markets develop.

The scope of the analysis of this report covers diagnostic and therapeutic modalities used in the management of cardiac rhythm disorders. Diagnostic modalities covered in this report include electrocardiography (ECG) systems and electrophysiology (EP) catheters. Therapeutic modalities discussed in this report include ablation catheters (surgical and transcatheter), cardiac resynchronization therapy (CRT) systems, external defibrillators, implantable cardioverter defibrillators (ICDs), and pacemakers.

Table of Contents

EXECUTIVE SUMMARY

  • i. Methodology
  • Exhibit ES-1: 2014, U.S. Cardiac Rhythm Management Market, Share by Products

1. CARDIAC RHYTHM DISORDERS OVERVIEW

  • 1.1. The Heart and Circulatory System
  • 1.2. The Cardiac Conduction System
  • 1.3. Selected Cardiac Rhythm Disorders
    • 1.3.1. Bradycardia
    • 1.3.2. Sick Sinus Syndrome
    • 1.3.3. Heart Block
    • 1.3.4. Tachycardia
    • 1.3.5. Atrial Fibrillation
    • 1.3.6. Ventricular Fibrillation
  • Exhibit 1-1: Cross-Section Diagrams of the Heart Illustrating the Direction of Blood Flow during Diastole and Systole
  • Exhibit 1-2: Cross-Section Diagrams of the Heart Valve Positions during Diastole and Systole
  • Exhibit 1-3: Diagram of Selected Coronary Arteries
  • Exhibit 1-4: Diagram of Cardiac Conduction System
  • Exhibit 1-5: Cardiac Arrhythmias, Selected Statistics

2. U.S. MARKETS FOR CARDIAC RHYTHM MANAGEMENT DEVICES

  • 2.1. Diagnostic Cardiac Rhythm Management Devices, Market Analysis
    • 2.1.1. Electrocardiography Products, Market Analysis
      • 2.1.1.1. Procedure Volumes
      • 2.1.1.2. Products
      • 2.1.1.3. Market Forecast
      • 2.1.1.4. Competitive Analysis
    • 2.1.2. Electrophysiology Products, Market Analysis
      • 2.1.2.1. Procedure Volumes
      • 2.1.2.2. Products
      • 2.1.2.3. Market Forecast
      • 2.1.2.4. Competitive Analysis
  • 2.2. Therapeutic Cardiac Rhythm Management Devices, Market Analysis
    • 2.2.1. Cardiac Resynchronization Therapy Products, Market Analysis
      • 2.2.1.1. Implantable Cardiac Pacing Systems
      • 2.2.1.2. Temporary Pacing Systems
      • 2.2.1.3. Procedure Volumes
      • 2.2.1.4. Products
      • 2.2.1.5. Market Forecast
      • 2.2.1.6. Competitive Analysis
    • 2.2.2. External Defibrillator Products, Market Analysis
      • 2.2.2.1. Placement Volumes
      • 2.2.2.2. Products
      • 2.2.2.3. Market Forecast
      • 2.2.2.4. Competitive Analysis
    • 2.2.3. Implantable Cardioverter Defibrillator Products, Market Analysis
      • 2.2.3.1. Procedure Volumes
      • 2.2.3.2. Products
      • 2.2.3.3. Market Forecast
      • 2.2.3.4. Competitive Analysis
    • 2.2.4. Cardiac Resynchronization Therapy, Market Analysis
      • 2.2.4.1. Cardiac Resynchronization Therapy Systems
      • 2.2.4.1. Procedure Volumes
      • 2.2.4.2. Products
      • 2.2.4.3. Market Forecast
      • 2.2.4.4. Competitive Analysis
    • 2.2.5. Arrhythmia Ablation
      • 2.2.5.1. Transcatheter Arrhythmia Ablation
      • 2.2.5.2. Transcatheter Ablation of Atrial Fibrillation
      • 2.2.5.3. Direct Energy-Based Surgical Ablation of Atrial Fibrillation
      • 2.2.5.4. Procedure Volumes
      • 2.2.5.5. Products
      • 2.2.5.6. Market Forecast
      • 2.2.5.7. Competitive Analysis
  • Exhibit 2-1: Cardiac Rhythm Management, Combined Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-2: Cardiac Rhythm Management Products, Combined Market Forecast, 2014-2019
  • Exhibit 2-3: Normal Electrocardiogram Tracing
  • Exhibit 2-4: Electrocardiography, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-5: Electrocardiography Products, Market Forecast, 2014-2019
  • Exhibit 2-6: 2014, Electrocardiography Products Market, Share by Supplier
  • Exhibit 2-7: Diagnostic Electrophysiology, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-8: Electrophysiology Systems, Market Forecast, 2014-2019
  • Exhibit 2-9: 2014, Electrophysiology Products Market, Share by Supplier
  • Exhibit 2-10: NBG Code for Implantable Pacemaker Systems
  • Exhibit 2-11: Cardiac Pacemaker Implantation, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-12: Pacemaker Products, Market Forecast, 2014-2019
  • Exhibit 2-13: 2014, Pacemaker Products Market, Share by Supplier
  • Exhibit 2-14: External Defibrillation, Placement Volumes Forecast, 2014-2019
  • Exhibit 2-15: External Defibrillator Products, Market Forecast, 2014-2019
  • Exhibit 2-16: 2014, External Defibrillator Products Market, Share by Supplier
  • Exhibit 2-17: NBD Code and Labeling for Implantable Cardioverter Defibrillators
  • Exhibit 2-18: Implantable Cardioverter Defibrillator Implantation, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-19: Implantable Cardioverter Defibrillator Products, Market Forecast, 2014-2019
  • Exhibit 2-20: 2014, Implantable Cardioverter Defibrillator Products Market, Share by Supplier
  • Exhibit 2-21: Cardiac Resynchronization Therapy, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-22: Cardiac Resynchronization Therapy Products, Market Forecast, 2014-2019
  • Exhibit 2-23: 2014, Cardiac Resynchronization Therapy Products Market, Share by Supplier
  • Exhibit 2-24: Cardiac Ablation, Procedure Volumes Forecast, 2014-2019
  • Exhibit 2-25: Cardiac Ablation Products, Market Forecast, 2014-2019
  • Exhibit 2-26: 2014, Transcatheter Ablation Systems Products Market, Share by Supplier
  • Exhibit 2-27: 2014, Surgical Ablation Systems Products Market, Share by Supplier

APPENDIX: COMPANY LISTING

Back to Top